Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Chapter 1 Ginsenosides
2008 Standout
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes
2005
Metabolic Syndrome: Treatment of Hypertensive Patients
2007
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Long-term Effects of Weight-Reducing Interventions in Hypertensive Patients<subtitle>Systematic Review and Meta-analysis</subtitle>
2008
Pioglitazone
2006
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
2008 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Diabetes Mellitus and Macrovascular Disease: Mechanisms and Mediators
2007
Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes
2008
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus
2011
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Chronic sildenafil in men with diabetes and erectile dysfunction
2007
Inhibition of the high affinity Ca2+-ATPase activity in rat liver plasma membranes following carbon tetrachloride intoxication
1990
Combined therapy in the treatment of dyslipidemia
2009
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Long-term effects of weight-reducing diets in hypertensive patients
2011
Surgery for morbid obesity
2005
Reactive intermediates and their toxicological significance
1988
Long-term effects of weight-reducing drugs in hypertensive patients
2009
Sexual dysfunction in men and women with endocrine disorders
2007
Long‐term changes in blood pressure following orlistat and sibutramine treatment: a meta‐analysis
2009
Long-term effects of weight-reducing drugs in hypertensive patients
2013
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Sexual Dysfunction After Simultaneous Pancreas–Kidney Transplantation
2008
The Role of Nitric Oxide in Erectile Dysfunction: Implications for Medical Therapy
2006
Prediabetes: a high-risk state for diabetes development
2012 Standout
Cardiac Remodeling in Obesity
2008
Telmisartan
2006
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Resistance to oxidative stress by hyperplastic and neoplastic rat liver tissue monitored in terms of production of unpolar and medium polar carbonyls
1986
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Membrane Cholesterol, Tumorigenesis, and the Biochemical Phenotype of Neoplasia
1981
Microvascular and Macrovascular Complications of Diabetes
2008 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Mechanisms of Diabetic Complications
2013 Standout
Cytotoxicity and metabolism of 4-hydroxy-2-nonenal and 2-nonenal in H2O2-resistant cell lines. Do aldehydic by-products of lipid peroxidation contribute to oxidative stress?
1990 StandoutNobel
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
2005
The Metabolic Syndrome
2008 Standout
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Surgery for weight loss in adults
2014 Standout
Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas. A new, membrane-permeant chelator of heavy metals reveals that these ascites tumor cell lines have normal cytosolic free Ca2+.
1985 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
2010
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome
2005
Extraction and partial characterization of dialysable products originating from the peroxidation of liver microsomal lipids and inhibiting microsomal glucose 6-phosphatase activity
1979
Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol.
1984
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
1990 Standout
Effects of diffusible products of peroxidation of rat liver microsomal lipids
1979
Molecular Characterization of New Selective Peroxisome Proliferator–Activated Receptor γ Modulators With Angiotensin Receptor Blocking Activity
2005
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Incidence of Metabolic Syndrome and Insulin Resistance in a Population with Organic Erectile Dysfunction
2005
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Gianandrea Bertone being referenced
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study
2004
Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients
2004
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial
2004
Comparison of fluvastatin + fenofibrate combination therapyand fluvastatin monotherapy in the treatment of combined hyperlipidemia,type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial
2004
Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic Patients
2004
Cholesterol and phospholipid composition of mitochondria and microsomes isolated from morris hepatoma 51 23 and rat liver
1973
Inhibition by aldehydes as a possible further mechanism for glucose-6-phosphatase inactivation during CCl4-poisoning
1977